Matsumoto G - Search Results

1

Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.

Matsumoto G, Namekawa J, Muta M, Nakamura T, Bando H, Tohyama K, Toi M, Umezawa K. Matsumoto G, et al. Clin Cancer Res. 2005 Feb 1;11(3):1287-93. Clin Cancer Res. 2005. PMID: 15709200

2

Enhancement of the caspase-independent apoptotic sensitivity of pancreatic cancer cells by DHMEQ, an NF-kappaB inhibitor.

Matsumoto G, Muta M, Umezawa K, Suzuki T, Misumi K, Tsuruta K, Okamoto A, Toi M. Matsumoto G, et al. Int J Oncol. 2005 Nov;27(5):1247-55. Int J Oncol. 2005. PMID: 16211219

3

Mechanical analysis of tumor growth regression by the cyclooxygenase-2 inhibitor, DFU, in a Walker256 rat tumor model: importance of monocyte chemoattractant protein-1 modulation.

Muta M, Matsumoto G, Nakashima E, Toi M. Muta M, et al. Among authors: matsumoto g. Clin Cancer Res. 2006 Jan 1;12(1):264-72. doi: 10.1158/1078-0432.CCR-05-1052. Clin Cancer Res. 2006. PMID: 16397051

4

Expression of macrophage migration inhibitory factor in human breast cancer: association with nodal spread.

Bando H, Matsumoto G, Bando M, Muta M, Ogawa T, Funata N, Nishihira J, Koike M, Toi M. Bando H, et al. Among authors: matsumoto g. Jpn J Cancer Res. 2002 Apr;93(4):389-96. doi: 10.1111/j.1349-7006.2002.tb01269.x. Jpn J Cancer Res. 2002. PMID: 11985788 Free PMC article.

5

Survival benefit of KRN7000 immune therapy in combination with TNP470 in hamster liver metastasis model of pancreatic cancer.

Matsumoto G, Nagai S, Muta M, Tsuruta K, Okamoto A, Toi M. Matsumoto G, et al. Oncol Rep. 2003 Sep-Oct;10(5):1201-6. Oncol Rep. 2003. PMID: 12883681

6

Study of cancer gene therapy using IL-12-secreting endothelial progenitor cells in a rat solid tumor model.

Muta M, Matsumoto G, Hiruma K, Nakashima E, Toi M. Muta M, et al. Among authors: matsumoto g. Oncol Rep. 2003 Nov-Dec;10(6):1765-9. Oncol Rep. 2003. PMID: 14534693

7

DFU, a selective COX-2 inhibitor, suppresses MCF-7 xenograft tumor growth in mice.

Matsumoto G, Rahman MA, Muta M, Nakamura T, Bando H, Saji S, Tsuruta K, Okamoto A, Toi M. Matsumoto G, et al. Oncol Rep. 2004 Aug;12(2):281-5. Oncol Rep. 2004. PMID: 15254689

8

[Antiangiogenesis therapy and hormone therapy--their resemblance and applications of prognostic and predictive factors].

Toi M, Matsumoto G, Bando H, Kuroi K. Toi M, et al. Among authors: matsumoto g. Gan To Kagaku Ryoho. 2000 Jul;27(8):1212-6. Gan To Kagaku Ryoho. 2000. PMID: 10945019 Japanese.

9

Impact of vasculogenesis on solid tumor growth in a rat model.

Muta M, Matsumoto G, Hiruma K, Saji S, Nakashima E, Toi M. Muta M, et al. Among authors: matsumoto g. Oncol Rep. 2003 Sep-Oct;10(5):1213-8. Oncol Rep. 2003. PMID: 12883683

10

Effect of low-dose Paclitaxel and docetaxel on endothelial progenitor cells.

Muta M, Yanagawa T, Sai Y, Saji S, Suzuki E, Aruga T, Kuroi K, Matsumoto G, Toi M, Nakashima E. Muta M, et al. Among authors: matsumoto g. Oncology. 2009;77(3-4):182-91. doi: 10.1159/000236016. Epub 2009 Sep 3. Oncology. 2009. PMID: 19729975

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters